Navigation Links
gloStream Announces Release of Microsoft-Based, Meaningful Use Certified gloEMR 6.0
Date:1/12/2011

TROY, Mich., Jan. 12, 2011 /PRNewswire/ -- gloStream, maker of gloEMR and gloPM – the only electronic medical record ("EMR") and practice management ("PM") software with Microsoft Office built right in – today announced the release of gloEMR 6.0., the sixth major upgrade to the gloEMR product line. Like its predecessor versions, gloEMR 6.0 leverages a variety of Microsoft technology such as the .NET platform, SQL Server and Microsoft Office so users have access to the most powerful and widely used technology available anywhere.

gloEMR offers a host of new features doctors can use to improve efficiency, productivity, and compliance with meaningful use criteria, which they must prove to collect Stimulus incentive funding.  This includes meaningful use and clinical quality measure dashboards that allow practice staff to track their compliance against all established criteria, in real time. In addition, the dashboards provide a mechanism for staff to pull data and report meaningful user status to the government, a key feature for all physicians seeking to acquire Stimulus funding.

"The tens of thousands of hours we've spent developing and testing gloEMR 6.0 have resulted in a product that is feature-rich, flexible and customizable to the specific needs of each practice we serve," said Piyush Khanna, gloStream's Chief Information Officer.  "gloEMR 6.0 provides doctors with important tools to ensure meaningful use compliance while also maximizing productivity via dashboards, personal health record integration, reporting and much, much more."

Additional, important key features within gloEMR include:

  • A fully customizable main dashboard homepage area.
  • HL7-standard Continuity of Care Documents ("CCDs") that can be sent and synched with other EMRs as well as personal health record applicat
    '/>"/>

SOURCE gloStream
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... July 30, 2015 IRIDEX Corporation (NASDAQ: ... second quarter 2015 financial results after the market closes ... with the release, the Company will host a conference ... Eastern Time on Thursday, August 6, 2015 ... other business developments. Interested parties may access ...
(Date:7/30/2015)...  Today we bring you a special edition of #MedicareMonday on Medicare,s 50 th ... of our Medicare resources and continue highlighting the success of the prescription drug benefit, ... Check out our latest infographics and videos here: http://onphr.ma/1INp9qQ ... ... ...
(Date:7/30/2015)... 2015 PTC Therapeutics, Inc. (NASDAQ: PTCT ... results for the second quarter ending June 30, 2015. ... across the organization.  We are excited to be near ... trial ever conducted with topline results expected in the ... Officer, PTC Therapeutics, Inc. "Translarna is now commercially available ...
Breaking Medicine Technology:IRIDEX Announces Second Quarter 2015 Conference Call and Release Date 2Happy 50th Anniversary Medicare! 2Happy 50th Anniversary Medicare! 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10
... June 29 Omnicell, Inc ., (Nasdaq: ... facilities, today announced that its OmniCenter® server has achieved VMware Ready™ ... and testing process managed by VMware and is now listed on ... , , ...
... June 29 Mylan Inc. (Nasdaq: MYL ) today ... the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug ... Arimidex® Tablets, a treatment for early breast cancer. , ... Anastrozole Tablets had U.S. sales of approximately ...
Cached Medicine Technology:Omnicell's OmniCenter Achieves VMware Ready(TM) Healthcare Virtualization Status 2Omnicell's OmniCenter Achieves VMware Ready(TM) Healthcare Virtualization Status 3Mylan Receives Approval for Generic Version of Arimidex® Tablets 2
(Date:8/1/2015)... ... August 01, 2015 , ... ... are in “a trending profession” that comprises a growing percentage of U.S. physicians, ... most. , That was one part of the message delivered by John W. ...
(Date:8/1/2015)... ... ... Tina Wilcoxson, owner of Freeport Maine’s Royal River Natural Foods, was named one ... Federation, the largest retail trade association in the world, for her “advocacy and engagement” ... named as such. According to the NRF’s website, Retail Champions are “Main Street business ...
(Date:8/1/2015)... ... August 01, 2015 , ... Lume Wellness creators Alex, Robert, and Sam have ... the Apple AppStore. , The app is designed to track various metrics of ... tool to view personal health and use this information for positive behavior modification. Lume ...
(Date:7/31/2015)... ... 31, 2015 , ... That’s right, the STASH awards have ... The Significant Technological Achievements in Secretive Horticulture (or STASH) Awards, featured in High ... that have stood the test of time. These include lighting products, organic and ...
(Date:7/31/2015)... , ... August 01, 2015 , ... Super Bowl 50 will emanate from ... League’s biggest day each year is the Super Bowl. In the two weeks that separate ... from the host venue. The 2016 Super Bowl game will mark the 50th time it ...
Breaking Medicine News(10 mins):Health News:COMP-Northwest Welcomes Class of 2019 2Health News:COMP-Northwest Welcomes Class of 2019 3Health News:COMP-Northwest Welcomes Class of 2019 4Health News:COMP-Northwest Welcomes Class of 2019 5Health News:Local Retail Advocate Wins National Recognition 2Health News:Lume Wellness Launches Health and Fitness Tracker iPhone App 2Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2
... prostate cancer earlier than ever before, but can,t accurately ... Health Research Institute,s Drs. John Lewis and Len Luyt, ... Ghrelin is a growth hormone produced by the ... cells are known to consume it at much higher ...
... Biomedical and Behavioral Research: Assessing the Necessity, a new ... request from the National Institutes of Health for expert ... research. The report will be released at a one-hour ... 15, in Room 100 of the National Academies, Keck ...
... is leading patients to seek out information about prescription ... in the International Journal Business and Systems Research. ... internet user through their physician there is a risk ... The direct advertising of pharmaceutical products to patients ...
... ANTONIO -- Obese patients with early-stage HER2-positive breast ... are normal weight or overweight, Mayo Clinic researchers found ... CTRC-AACR San Antonio Breast Cancer Symposium . HER2-positive breast ... epidermal growth factor receptor 2 that promotes cancer cell ...
... Mont., Dec. 7, 2011 LigoCyte Pharmaceuticals, Inc. ... protection against norovirus infection and related gastrointestinal illness ... sometimes referred to as "the stomach flu" is ... nausea, vomiting, abdominal cramps and diarrhea afflicting 21 ...
... 7 (HealthDay News) -- Obese women with early stage breast ... are of normal weight, new research suggests. Researchers from ... Wednesday at the 2011 San Antonio Breast Cancer Symposium. ... obesity, in general, increases a patient,s chance for having a ...
Cached Medicine News:Health News:Pharmaceutical spam 2Health News:Mayo Clinic: Obese patients with HER2-positive breast cancer may have worse outcomes 2Health News:NEJM publishes study showing LigoCyte's norovirus vaccine demonstrates protection against illness 2Health News:NEJM publishes study showing LigoCyte's norovirus vaccine demonstrates protection against illness 3Health News:NEJM publishes study showing LigoCyte's norovirus vaccine demonstrates protection against illness 4Health News:Obesity Linked to Worse Outcomes With Early Breast Cancer 2
Graether Collar Button micro iris retractor....
Round serrated handle, polished finish, overall length 130 mm....
... lens care solutions, when used ... ease of patient compliance in ... storage, wetting, rewetting and in-the-eye ... lenses (RGP or PMMA) of ...
Menicon Z is a rigid gas lens with high oxygen permeability. As one of its specific characteristics, it can provide superior visual correction and show excellent performance against astigmatism....
Medicine Products: